DVAX

DVAX

Dynavax Technologies Corporation Common Stock

$10.400+0.000 (0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$10.400

最高

$10.400

最低

$10.400

交易量

1.30M

公司基本面

交易統計

相關新聞

PR Newswire

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

查看更多
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
BusinessWire

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Deep Track's Nominees Are Prepared to Collectively Enter the Boardroom with Open-Minded Perspectives, Constructive Approach and Sole Focus on Creating Value for All Shareholders Believes that Without Meaningful Board

查看更多
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
PR Newswire

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

查看更多
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
PR Newswire

Dynavax Comments on Glass Lewis Recommendation

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

查看更多
Dynavax Comments on Glass Lewis Recommendation
BusinessWire

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Glass Lewis Recommends Shareholders Vote FOR Deep Track Nominees Brett Erkman and Donald Santel and AGAINST Chairman Scott Myers and Director Brent MacGregor Notes that "Deep Track has Highlighted Valid and Critical

查看更多
Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies
PR Newswire

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...

BusinessWire

Deep Track Capital Comments on ISS Recommendation

Strongly Disagrees with Recommendation and Believes ISS Ignored Key Issues in Its Incomplete Analysis ISS Has Chosen Not to Hold the Board Accountable for Its Underperformance in Recent Years, Heplisav's Waning Market